Use of a CD40:CD154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
A Standard patent application filed on 15 May 1998 credited to Kirk, Allan D. ; Harlan, David M ; Burkly, Linda ; Kauffman, Michael ; Thomas, David

Details

Application number :

74940  

Application type :

Standard  

Application status :

CEASED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Use of a CD40:CD154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection  

Inventor :

Kirk, Allan D. ; Harlan, David M ; Burkly, Linda ; Kauffman, Michael ; Thomas, David  

Agent name :

Cullens Patent and Trade Mark Attorneys  

Address for service :

GPO Box 1074 BRISBANE QLD 4001  

Filing date :

15 May 1998  

Associated companies :

 

Applicant name :

Biogen Idec MA Inc.  

Applicant address :

14 Cambridge Center, Cambridge, MA 02142, United States of America  

Old name :

Biogen, Inc. ; United States of America as represented by the Secretary of the Navy, The  

Original Source :

Go